Personalis, Inc. (PSNL) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Personalis, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.115 Good afternoon and welcome to the Personale's Third Quarter 2025 Earnings 00:00:05.115 -- 00:00:06.657 Conference. 00:00:06.657 -- 00:00:10.120 All participants will be in listen-only mode. 00:00:10.120 -- 00:00:14.222 A question and answer session will follow the formal presentation. 00:00:14.403 -- 00:00:19.528 If anyone should require operator assistance during the conference, please key in star 00:00:19.528 -- 00:00:23.071 and then zero on your telephone keypad. 00:00:23.071 -- 00:00:25.613 Please note that this event is being recorded. 00:00:25.613 -- 00:00:31.271 I will now hand it over to Caroline Corder, of Investor Relations. 00:00:31.271 -- 00:00:33.353 Please go ahead. 00:00:33.353 -- 00:00:38.477 Thank you, Operator. Welcome to PersonAlysis Third Quarter 2025 Earnings Call. 00:00:38.477 -- 00:00:43.382 Joining today's call are Chris Hall, Chief Executive Officer and President, Erin Toshibana, 00:00:43.382 -- 00:00:47.826 Chief Financial and Chief Operating Officer, and Rich Chen, Chief Medical Officer and 00:00:47.826 -- 00:00:49.988 EVP R&D. 00:00:49.988 -- 00:00:53.271 All statements made on this call that do not relate to matters of historical fact should 00:00:53.271 -- 00:00:55.953 be considered forward-looking statements within the meaning of the U.S. 00:00:55.953 -- 00:01:00.342 security laws. For example, any statements regarding trends and expectations for our 00:01:00.342 -- 00:01:05.107 financial performance this year and longer term, cash runway and liquidity position, 00:01:05.107 -- 00:01:10.972 revenue expectations and timing, size and booking of orders, products, services, technology, 00:01:10.972 -- 00:01:15.256 expansion of clinical volume, reimbursement goals, the outcome and timing of reimbursement 0...